Integrating EPA in CV risk reduction strategies: practical experience and guidance
Event: ESC Congress 2024
Topic: Risk Factors and Prevention
Session: Clinical scenarios addressing residual risk in atherosclerotic cardiovascular disease (ASCVD): understanding the role of triglycerides and eicosapentaenoic acid (EPA)
